Last reviewed · How we verify
NCT05418634
Point-of-care EEG in the Pediatric Emergency Department
trial testing point of care EEG in Status Epilepticus in 200 participants. Completed in 24 August 2025.
23 August 2025
Quick facts
| Lead sponsor | University Children's Hospital, Zurich |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 24 August 2022 |
| Primary completion | 23 August 2025 |
| Estimated completion | 24 August 2025 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- point of care EEG
Conditions studied
- Status Epilepticus — all drugs for Status Epilepticus →
- Non-Convulsive Status Epilepticus — all drugs for Non-Convulsive Status Epilepticus →
- Altered Mental Status — all drugs for Altered Mental Status →
Sponsor
University Children's Hospital, Zurich
Who can join
Under 18, any sex, with Status Epilepticus or Non-Convulsive Status Epilepticus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The researchers investigate the use of a simplified electroencephalogram (point-of-care EEG) in the pediatric emergency department for children with impaired consciousness or an ongoing epileptic seizure ("status epilepticus"). In addition, the researchers will compare the simplified EEG with the conventional EEG in the epilepsy outpatient clinic.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05418634
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Status Epilepticus
Currently open trials in the same condition.
- NCT06401707 — PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest · Phase 2 · recruiting
- NCT06194747 — Improving Status Epilepticus Treatment Times · NA · recruiting
- NCT06017973 — The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus · NA · recruiting
- NCT05851391 — buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest · Phase 2 · recruiting
- NCT05839418 — Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status · recruiting
Other University Children's Hospital, Zurich trials
Trials by the same sponsor.
- NCT07415577 — The Use of Cultured (Dermal) Epithelial Autografts in Severely Burned Patients · not yet recruiting
- NCT06852313 — Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents · NA · recruiting
- NCT07368166 — Development of the PTSD-iMPACT to Measure PTSD-Related Functional Impairment in Children and Adolescents - A Validation · recruiting
- NCT06950047 — PediLoc® Blade Plate in Distal Femoral Osteotomies · completed
- NCT05971264 — Comparison of Bladder Pressure Versus Regional Intestinal Tissue Oxygenation in Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05418634 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Children's Hospital, Zurich
- Last refreshed: 4 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05418634.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing